Global Pharmaceutical Marijuana (MMJ) Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Pharmaceutical Marijuana (MMJ) Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Pharmaceutical Marijuana (MMJ) report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Pharmaceutical Marijuana (MMJ) market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Cancer and Arthritis are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Pharmaceutical Marijuana (MMJ) industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Pharmaceutical Marijuana (MMJ) key manufacturers include Canopy Growth Corporation, GW Pharmaceuticals, plc, Aurora Cannabis, Inc., Aphria, Inc., MedReleaf Corporation, Insys Therapeutics, Inc., CanniMed Therapeutics, Inc., Cara Therapeutics, Inc. and United Cannabis Corporation, etc. Canopy Growth Corporation, GW Pharmaceuticals, plc, Aurora Cannabis, Inc. are top 3 players and held % sales share in total in 2022.
Pharmaceutical Marijuana (MMJ) can be divided into THC-dominant, CBD-dominant and Balanced THC & CBD,, etc. THC-dominant is the mainstream product in the market, accounting for % sales share globally in 2022.
Pharmaceutical Marijuana (MMJ) is widely used in various fields, such as Cancer, Arthritis, Migraine and Epilepsy, etc. Cancer provides greatest supports to the Pharmaceutical Marijuana (MMJ) industry development. In 2022, global % sales of Pharmaceutical Marijuana (MMJ) went into Cancer filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pharmaceutical Marijuana (MMJ) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Canopy Growth Corporation
GW Pharmaceuticals, plc
Aurora Cannabis, Inc.
Aphria, Inc.
MedReleaf Corporation
Insys Therapeutics, Inc.
CanniMed Therapeutics, Inc.
Cara Therapeutics, Inc.
United Cannabis Corporation
Segment by Type
THC-dominant
CBD-dominant
Balanced THC & CBD
Cancer
Arthritis
Migraine
Epilepsy
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Pharmaceutical Marijuana (MMJ) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Pharmaceutical Marijuana (MMJ), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Pharmaceutical Marijuana (MMJ) industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Pharmaceutical Marijuana (MMJ) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Pharmaceutical Marijuana (MMJ) introduction, etc. Pharmaceutical Marijuana (MMJ) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Pharmaceutical Marijuana (MMJ) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
North America, Europe and Asia Pacific are the key regions for Pharmaceutical Marijuana (MMJ) industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Pharmaceutical Marijuana (MMJ) key manufacturers include Canopy Growth Corporation, GW Pharmaceuticals, plc, Aurora Cannabis, Inc., Aphria, Inc., MedReleaf Corporation, Insys Therapeutics, Inc., CanniMed Therapeutics, Inc., Cara Therapeutics, Inc. and United Cannabis Corporation, etc. Canopy Growth Corporation, GW Pharmaceuticals, plc, Aurora Cannabis, Inc. are top 3 players and held % sales share in total in 2022.
Pharmaceutical Marijuana (MMJ) can be divided into THC-dominant, CBD-dominant and Balanced THC & CBD,, etc. THC-dominant is the mainstream product in the market, accounting for % sales share globally in 2022.
Pharmaceutical Marijuana (MMJ) is widely used in various fields, such as Cancer, Arthritis, Migraine and Epilepsy, etc. Cancer provides greatest supports to the Pharmaceutical Marijuana (MMJ) industry development. In 2022, global % sales of Pharmaceutical Marijuana (MMJ) went into Cancer filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pharmaceutical Marijuana (MMJ) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Canopy Growth Corporation
GW Pharmaceuticals, plc
Aurora Cannabis, Inc.
Aphria, Inc.
MedReleaf Corporation
Insys Therapeutics, Inc.
CanniMed Therapeutics, Inc.
Cara Therapeutics, Inc.
United Cannabis Corporation
Segment by Type
THC-dominant
CBD-dominant
Balanced THC & CBD
Segment by Application
Cancer
Arthritis
Migraine
Epilepsy
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Pharmaceutical Marijuana (MMJ) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Pharmaceutical Marijuana (MMJ), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Pharmaceutical Marijuana (MMJ) industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Pharmaceutical Marijuana (MMJ) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Pharmaceutical Marijuana (MMJ) introduction, etc. Pharmaceutical Marijuana (MMJ) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Pharmaceutical Marijuana (MMJ) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices